# Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

> **NCT00231335** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT00231335
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231335, "Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00231335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*